Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin plus ramipril for diabetic nephropathy in type 2 diabetes
2013-004042-42Phase 4Unknown
- Sponsor
- King's College London
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dapagliflozin in diabetic glomerulosclerosis (2 arms), sponsored by King's College London. Primary endpoint: Change in albuminuria. Status: unknown.
02
Drugs
dapagliflozin
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on 2013-004042-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004042-42.